Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 5, 2009, Pages 366-370

  Miesbach, Wolfgang ^a,d   Galanakis, Dennis ^b   Scharrer, Inge ^c  

^a GOETHE UNIVERSITY   (Germany)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Abortion; Bleeding; Dysfibrinogenemia; Pregnancy; Thrombosis

Indexed keywords

BATROXOBIN; ENOXAPARIN; FIBRINOGEN; HAEMOCOMPLETTAN; UNCLASSIFIED DRUG;

ABORTION; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DELIVERY; DRUG BLOOD LEVEL; DYSFIBRINOGENEMIA; FEMALE; GENE MUTATION; HUMAN; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RETROSPECTIVE STUDY; SUBSTITUTION THERAPY; THROMBOSIS;

ABORTION, HABITUAL; ABRUPTIO PLACENTAE; ADULT; AFIBRINOGENEMIA; ENOXAPARIN; FEMALE; FIBRINOGEN; FIBRINOGENS, ABNORMAL; HEMORRHAGE; HUMANS; INFANT, NEWBORN; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY TRIMESTER, FIRST; PROTHROMBIN TIME; PUERPERAL DISORDERS; RETROSPECTIVE STUDIES; THROMBIN TIME; THROMBOEMBOLISM; THROMBOSIS;

EID: 68149091639     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32832aec2b     Document Type: Article

References (26)

1. Martinez J. Congenital dysfibrinogenemia. Curr Opin Hematol 1997; 4:357-365.
2. Hanss M, Biot F. A database for human fibrinogen variants. Ann N Y Acad Sci 2001; 936:89-90.
3. Acharya SS, Coughlin A, Dimichelle DM. North American Rare Bleeding Disorder Study Group. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2:248-256.
4. Haverkate F, Samama M. Familial dysfibrogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen. Thromb Haemost 1995; 73:151-161.
5. Terasawa F, Hogan KA, Kani S, Hirose M, Eguchi Y, Noda Y, et al. Fibrinogen Otsu I: A γAsn319, Asp320 deletion dysfibrinogen identified in an asymptomatic pregnant women. Thromb Haemost 2003; 90:757-758.
6. Mathonnet F, Guillon L, Detruit H, Mazmanian GM, Dreyfus M, Alvarez JC, et al. Fibrinigen Poissy II (γN361K): a novel dysfibrogenemia associated with defective polymerization and Peptide B release. Blood Coagul Fibrinolysis 2003; 14:293-298.
7. Takala T, Okasa H, Rasi V, Tuimala R. Dysfibrinogenemia associated with thrombosis and third-trimester fetal loss. A case report. Reprod Med 1991; 36:410-412.
8. Edwards RZ, Rijsinghani A. Dysfibrogenemia and placental abruption. Obstet Gynecol 2000; 95:1043.
9. Yamanaka Y, Takeuchi K, Sugimoto M, Sato A, Nakago S, Maruo T. Case report dysfibrogenemia during pregnancy treated successfully with fibrinogen. Acta Obstet Gynecol Scand 2003; 82:972-973.
10. Franchini M, Raffaelli R, Musola M, Memmo A, Poli G, Franchi M, et al. Management of inherited dysfibrinogenemia during pregnancy: a description of four consecutive cases. Ann Hematol 2007; 86:693-694.
11. Three new cases of dysfibrinogenemia Poissy III, Saint-Germain I and Tahiti. Thrombosis Res 2001; 103:201-207.
12. Roberts HR. The dysfibrinogenaemias. Br J Haematol 2001; 114:249-257.
13. Stucki B, Zenhäusern R, Biedermann B, Baudo F, Redaelli R, Lämmle B, Furlan M. Fibrinogen Bern IV, Bern V and Milano XI: three dysfunctional variant with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain. Blood Coagul Fibrinolysis 1999; 10:93-99.
14. Marchi R, Meyer M, de Bosch N, Soria J, Arocha-Pin̄ango CL, Weisel JW. Biophysical characterization of fibrinogen Caracas I with an Aα-chain truncation at Aα-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen. Blood Coagul Fibrinolysis 2004; 15:285-293.
15. Galanakis D, Neerman-Arbez M, Scheiner T, Henschen A, Hubbs D, Nagaswami C, Weisel JW. Homophenotipic A(alpha) R16 fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release. Blood Coagul Fibrinolysis 2007; 18:731-737.
16. Kotlin R, Chytilová M, Suttnar J, Riedel T, Salaj P, Blatný J, et al. Fibrinogen Novy Jičin and Praha II: cases ofhereditaryAαArg →Cys and Aα 16Arg → His dysfibrogenemia. Thromb Res2007; 121:75-84.
17. Lefebvre P, Velasco PT, Dear A, Lounes KG, Lord ST, Brennan SO, et al. Severe Hypodysbibrogenemia in compound heterozygotes of fibrinogen AαIVS4+1G>T mutation and an AαGln328 truncation (Fibrinigen Keokuk). Blood 2004; 103:2571-2576.
18. Ridgway HJ, Brennan SO, Gibbons S, George PM. Fibrinogen Lincoln: a new truncated a chain variant with delayed clotting. Br J Haematol 1996; 93:177-184.
19. Fuchs G, Egbring R, Havermann. Fibrinogen Marburg: a new genetic variant of fibrinogen. Blut 1977; 34: 107-118.
20. Collen A, Maas A, Kooistra T, Lupu F, Grimbergen J, Haad FJ, et al. Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aα-chain, alters endothelial capillary tube formation. Blood 2001; 97:973-980.
21. Furlan M, Steinmann C, Jungo M, Laemmle B. Binding of calcium ions and their effect on clotting of fibrinogen Milano III, a variant with truncated Aα chains. Blood Coagul Fibrinolysis 1996; 7:331-335.
22. Siebenlist KR, Mosesson MW, Meh DAS, DiOrio JP, Albrecht RM, Olson JD. Coexisting dysfibrinogenemia (gamma R275C) and factor V Leiden deficiency associated with thromboembolic disease(fibrinogen Cedar Rapids). Blood Coagul Fibrinolysis 2000; 11:293-304.
23. Evron S, Anteby SO, Brzezinski A, Samueloff A, Eldor A. Congenital afibrogenemia and recurrent early abortion: a case report. Eur J Obstet Gynecol Reprod Biol 1985; 19:307-311.
24. Inamoto Y, Terao T. First report of congenital afibrogenemia with successful delivery. Am J Obstet Gynecol 1985; 153:803-804.
25. Kobayashi T, Kanayama N, Tokunaga N, Asahina T, Terao T. Prenatal and peripartum management of congenital afibrinogenemia. Br J Haematol 2000; 109:364-366.
26. Kalina U, Stöhr HA, Bickhard H, Knaub S, Siboni SM, Mannucci PM, Peyvandi F. Rotational thrombelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency. Blood Coagul Fibrinolysis 2008; 19:777-783.